Floyd E. Romesberg
Corporate Officer/Principal at The Scripps Research Institute
Profile
Floyd E.
Romesberg is the founder of Achaogen, Inc. (founded in 2002), RQx Pharmaceuticals, Inc. (founded in 2010), and Synthorx, Inc. (founded in 2014).
He is currently working as a Professor at The Scripps Research Institute since 1998.
Dr. Romesberg's education includes a graduate and doctorate degree from Cornell University and an undergraduate degree from The Ohio State University.
Floyd E. Romesberg active positions
| Companies | Position | Start |
|---|---|---|
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 1997-12-31 |
Former positions of Floyd E. Romesberg
| Companies | Position | End |
|---|---|---|
| SYNTHORX, INC. | Founder | 2019-09-11 |
RQx Pharmaceuticals, Inc.
 RQx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RQx Pharmaceuticals, Inc. operates as a biopharmaceutical company developing small molecule antibiotics. The firm develops small molecule antibiotics to combat serious life threatening infections, including those caused by multi drug-resistant Gram-negative bacteria. It is developing novel, first-in-class antibiotics that evade the current abundance of antibiotic resistance mechanisms, which are now common across the globe. The company was founded in 2010 and is headquartered in La Jolla, CA. | Founder | 2012-12-31 |
| ACHAOGEN | Founder | 2010-12-31 |
Training of Floyd E. Romesberg
| Cornell University | Doctorate Degree |
| The Ohio State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
RQx Pharmaceuticals, Inc.
RQx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RQx Pharmaceuticals, Inc. operates as a biopharmaceutical company developing small molecule antibiotics. The firm develops small molecule antibiotics to combat serious life threatening infections, including those caused by multi drug-resistant Gram-negative bacteria. It is developing novel, first-in-class antibiotics that evade the current abundance of antibiotic resistance mechanisms, which are now common across the globe. The company was founded in 2010 and is headquartered in La Jolla, CA. | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Floyd E. Romesberg
